Your browser doesn't support javascript.
loading
PU.1 cooperates with IRF4 and IRF8 to suppress pre-B-cell leukemia.
Pang, S H M; Minnich, M; Gangatirkar, P; Zheng, Z; Ebert, A; Song, G; Dickins, R A; Corcoran, L M; Mullighan, C G; Busslinger, M; Huntington, N D; Nutt, S L; Carotta, S.
Afiliación
  • Pang SH; Molecular Immunology Department, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Minnich M; Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia.
  • Gangatirkar P; The Institute of Molecular Pathology, Vienna, Austria.
  • Zheng Z; Molecular Immunology Department, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Ebert A; Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia.
  • Song G; Molecular Immunology Department, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Dickins RA; The Institute of Molecular Pathology, Vienna, Austria.
  • Corcoran LM; Department of Pathology, St Jude Children's Research Hospital, Memphis, TN, USA.
  • Mullighan CG; Molecular Immunology Department, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Busslinger M; Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia.
  • Huntington ND; Molecular Immunology Department, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Nutt SL; Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia.
  • Carotta S; Department of Pathology, St Jude Children's Research Hospital, Memphis, TN, USA.
Leukemia ; 30(6): 1375-87, 2016 06.
Article en En | MEDLINE | ID: mdl-26932576
The Ets family transcription factor PU.1 and the interferon regulatory factor (IRF)4 and IRF8 regulate gene expression by binding to composite DNA sequences known as Ets/interferon consensus elements. Although all three factors are expressed from the onset of B-cell development, single deficiency of these factors in B-cell progenitors only mildly impacts on bone marrow B lymphopoiesis. Here we tested whether PU.1 cooperates with IRF factors in regulating early B-cell development. Lack of PU.1 and IRF4 resulted in a partial block in development the pre-B-cell stage. The combined deletion of PU.1 and IRF8 reduced recirculating B-cell numbers. Strikingly, all PU.1/IRF4 and ~50% of PU.1/IRF8 double deficient mice developed pre-B-cell acute lymphoblastic leukemia (B-ALL) associated with reduced expression of the established B-lineage tumor suppressor genes, Ikaros and Spi-B. These genes are directly regulated by PU.1/IRF4/IRF8, and restoration of Ikaros or Spi-B expression inhibited leukemic cell growth. In summary, we demonstrate that PU.1, IRF4 and IRF8 cooperate to regulate early B-cell development and to prevent pre-B-ALL formation.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Transactivadores / Proteínas Proto-Oncogénicas / Factores Reguladores del Interferón Límite: Animals Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Transactivadores / Proteínas Proto-Oncogénicas / Factores Reguladores del Interferón Límite: Animals Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Australia